Research

Area 3

Genomic Programming of Beta Cells and Diabetes

Team leader

Strategic objectives

  1. Use of genomic tools for establishing the genetic and epigenetic mechanisms that modify the risk of developing diabetes.
  2. Identification of pathogenic mechanisms and new therapeutic options for monogenic forms of diabetes.
  3. Discovery of new pancreatic regeneration pathways.

Main lines of research
  1. Pancreatic regeneration and programming
  2. Epigenomic regulation of beta cells and diabetes
  3. Monogenic diabetes.

For further information, see www.betacellregulation.net